Skip to Main Content

Paper Details

Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
Proc Natl Acad Sci U S A
125
1998
Author NameAffiliation
Shuling ZhangNational Cancer Institute, National Institutes of Health
  • 1 - 1

Datasets

Release 1.2